Schiff gets 2nd takeover offer

Share this article:

Consumer goods firm Reckitt Benckiser commenced a tender offer for vitamin and supplement company Schiff valued at $200 million more than an acquisition deal Schiff already signed with Bayer HealthCare.

Reckitt's bid for Schiff came in at $42.00 per share in cash, valuing Schiff at $1.4 billion—a 23.5% premium over Bayer's bid.

On October 30, Schiff signed a deal to be acquired by Bayer Healthcare in a transaction valued at $1.2 billion.

Schiff markets OTC brands Omega 3 supplement MegaRed and Airborne immune system health supplement, as well as nutrition bars and vitamins.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.